Latest Form 4 insider transactions

Mark Elliott Boulding, EXEC. VP AND CLO of Ptc Therapeutics, Inc., sold 192 shares of common stock on October 9, 2026 for $64.26 per share.

Jeffrey D Rowe, a Director of Rpm International Inc/De/, received 1,700 shares of common stock on October 8, 2026.

Vicky Sutil, a Director of ANTERO RESOURCES Corp, received 1,497 shares of common stock on October 10, 2026.

W Howard Keenan Jr, a Director of Antero Midstream Corp, received 2,015 shares of common stock on October 10, 2026.

W Howard Keenan Jr, a Director of ANTERO RESOURCES Corp, received 1,497 shares of common stock on October 10, 2026.

ISQ Global Fund II GP LLC and 4 others reported changes in beneficial ownership of Kinetik Holdings Inc. common stock on October 8, 2026.

Jarrad Mattieu Aguirre, Chief Medical Officer of Lyell Immunopharma, Inc., sold 422 shares of common stock on October 12, 2026 for $8.63 per share.

Brooks J Klimley, a Director of Antero Midstream Corp, received 2,015 shares of common stock on October 10, 2026.

Ellen M Pawlikowski, a Director of Rpm International Inc/De/, received 1,700 shares of common stock on October 8, 2026.

Patrick Industries and LCI Industries have received a second request for information from the DOJ, extending the regulatory review period for their proposed merger.

Benjamin A. Hardesty, a Director of ANTERO RESOURCES Corp, received 2,019 shares of common stock on October 10, 2026.

Brenda R Schroer, a Director of ANTERO RESOURCES Corp, received 1,497 shares of common stock on October 10, 2026.

Frederick R. Nance, a Director of Rpm International Inc/De/, received 1,700 shares of common stock on October 8, 2026.

NuCube Energy is developing its NuSun platform for modular, behind-the-meter deployment to provide firm, round-the-clock power for data centers.

David H Keyte, a Director of Antero Midstream Corp, received 3,408 shares of common stock on October 10, 2026.

Jacqueline C Mutschler, a Director of ANTERO RESOURCES Corp, received 1,497 shares of common stock on October 10, 2026.

Vincent Roche, Chair & CEO and a Director of Analog Devices Inc, reported a transaction in 13,305 shares of common stock on October 12, 2026.

Gilbert Lynn Marks, a Director of AN2 Therapeutics, Inc., received 2,283 shares of common stock on October 12, 2026.

Patricia A. Martin, a Director of AN2 Therapeutics, Inc., received 389 shares of common stock on October 12, 2026.

Craig S Morford, a Director of Rpm International Inc/De/, received 1,700 shares of common stock on October 8, 2026.

Kabeer Aziz, a Director of AN2 Therapeutics, Inc., received 2,465 shares of common stock on October 12, 2026.

Eureka Acquisition Corp announced it has regained compliance with Nasdaq's minimum public holder requirement, ensuring its continued listing on the Nasdaq Capital Market.

Alex M Azar Ii, a Director of Guardant Health, Inc., reported multiple transactions in common stock on October 12, 2026.

Christopher L Mapes, a Director of Rpm International Inc/De/, received 1,700 shares of common stock on October 8, 2026.

Nicholas P. Parker, EVP, Worldwide Field Ops of Nvidia Corp, received 160,418 shares of common stock on September 9, 2026.

Robert Livingston, a Director of Rpm International Inc/De/, received 1,700 shares of common stock on October 8, 2026.

Tiffany Eul Davis Inglis, Chief Medical Officer of Sera Prognostics, Inc., sold 8,024 shares of common stock on October 12, 2026 for $2.03 per share.

Michael B. Strand, Chief Revenue Officer of Mynd.ai, Inc., reported a transaction in 4,216 shares of common stock on October 9, 2026.

Allyson G. Krause, General Counsel of Mynd.ai, Inc., reported a transaction in 20,769 shares of common stock on October 9, 2026.

Arthur G. Giterman, CEO and CFO and a Director of Mynd.ai, Inc., reported a transaction in 65,407 shares of common stock on October 9, 2026.